vaccineinduced seropositivity visp phenomenon wherein person received vaccine disease would thereafter give positive reactive test result disease tested despite actually disease happens many vaccines encourage body produce antibodies particular disease blood tests often determine whether person antibodies regardless whether came infection vaccination visp especially concern vaccine trials hiv vaccine research people give positive result hiv test even result vaccine infection may face discrimination hiv infection america first hiv vaccine hiv vaccines tested continually worldwide since thus far one developed vaccine reduces persons risk contracting hiv exposed viruscitation needed many hiv tests work checking persons blood hiv rather determining whether bodys antibodies hiv present bloodcitation needed hiv vaccines designed intent promote bodys production antibodies would combat hivcitation needed regardless whether effective stimulating production antibodies fight hiv usually cause body produce antibodies standard hiv tests recognize antibodies hiv positive person would produce response hiv infectioncitation needed person hiv negative received hiv vaccine tests positive hiv test said positive vispcitation needed hivnegative person exhibits visp gets hivpositive result test person may difficulty donating blood negotiating life insurance number persons received experimental hiv vaccinations number considered small difficulties determining difference antibodies produced hiv infection vaccineinduced antibodies managed individual vaccine research sites special capability conduct additional laboratory testing small pool vaccine recipients however time two new studies step study us rv study thailand greatly increased number people received hiv vaccinations another came increased need raise awareness visp people exhibiting itcitation needed international aids conference presenters talked need community healthcare providers understand patients hiv vaccine trial patients likely give false positive hiv test hiv vaccine research happens worldwide ensure vaccine researchers develop could used people worldwide developing countries limited access healthcare problems associated visp special concerncitation needed researchers africa asia north america south america said getting local government media support research essential addition creating facilities distinguishing hiv positive individuals individuals exhibiting people participate vaccine trials test hiv vaccines may exhibit visp years rest livescitation needed study done participants hiv vaccine trials network hiv vaccination studies showed among hiv negative participants received vaccine visp however occurrence visp varied depending kind vaccine participants person gets hepatitis b vaccine common test hepatitis b show positive usual course action case give person panel tests hbsag antihbc antihbs hepatitis b surface antigen antihepatitis b core antihepatitis b surface person never exposed hepatitis b gotten vaccine positive antihbs negative two tests panel combinations positive negative test mean things acute chronic past visp often practical concern diseases cases good vaccines already exist people access healthcare receive also physicians routinely test people recent infections diseases hiv medical literature visp diseases widely available little practical need researchcitation needed httpsenwikipediaorgwikivaccineinducedseropositivity